Despite availability of effective vaccines and guidelines for vaccination of high-risk adults against hepatitis A and B, [1] [2] [3] national vaccination goals have yet to be achieved, 4 and the incidence of hepatitis A and B among adults remains unacceptably high. 5, 6 Integration of hepatitis vaccination in settings serving those at highest risk is challenging, and a lack of dedicated federal funding for support of vaccines for adults is a significant barrier. 5, [7] [8] [9] [10] [11] Missed opportunities to vaccinate adults in various settings abound. 5, [7] [8] [9] [10] This article describes a statewide program to provide hepatitis A and B vaccination to adults at high risk.
Since 1995, the New York State Department of Health (NYSDOH) Adult Hepatitis Vaccination Program (AHVP) has focused on vaccinating high-risk adults. The AHVP, directed by the NYSDOH Hepatitis B Coordinator, provides outreach, education, and technical assistance to providers, health departments, and hospitals regarding hepatitis vaccination and other hepatitis-related issues. Assistance comes from dataentry and support staff, as well as four regional adult immunization coordinators. The Immunization Program's Vaccine Unit distributes vaccines to vaccination sites. Each of the 57 local health departments (LHDs) outside of New York City (NYC) has an immunization coordinator who promotes vaccination of high-risk adults and coordinates local vaccination efforts. The NYC Department of Health and Mental Hygiene (NYC DOHMH) has offered hepatitis vaccination at all public sexually transmitted disease (STD) clinics in the five counties of NYC since 2000.
With dedicated state funding for the purchase of vaccine for adults, hepatitis B vaccination was initiated in 1995 in public STD clinics, in collaboration with the NYSDOH Bureau of STD Control (BSTDC). Multiple factors, including competing priorities, concern over the stability of funding for vaccine, and feasibility issues, resulted in slow enrollment by the 57 NYS counties outside of NYC. 2 meetings were held with the AHVP to explore expanding access to vaccine for MSM and others receiving HIV/AIDS services. Because many HIV prevention providers do not administer vaccine, they were encouraged to contact LHDs for information on how to refer individuals for free vaccine. LHDs were encouraged to reach out to HIV prevention programs. Guidance for integrating hepatitis education and information into HIV programs and services and how to obtain free materials on viral hepatitis was provided. For example, a 21-question, self-administered integrated risk-assessment tool was developed in English and Spanish to collect information regarding behaviors that may put the client at risk of STD, HIV, or hepatitis infection. Clients may choose not to disclose specific risk(s), as it could be a barrier to vaccination. Instructions and an answer guide for clinic staff were also developed. sponsored by the BSTDC and others by the AIDS Institute-reached 6,563 participants, including physicians, nurse practitioners, nurses, physician assistants, HIV test counselors, other health and human professionals from state and county health departments, hospitals, community health centers, county jails, juvenile detention centers, state prisons, substance abuse treatment programs, community-based HIV/AIDS organizations, and others. These training programs helped promote the use of hepatitis vaccines in a variety of settings where adults at high risk seek services.
In September 2003, the AIDS Institute Office of the Medical Director received a competitive award from the CDC to develop, evaluate, and disseminate a national training curriculum on viral hepatitis. The training addresses basic information about hepatitis A, B, and C, with emphasis on integration of viral hepatitis services in HIV/AIDS programs, public health and STD programs, correctional settings, and substance use programs. 17 The AHVP participated in development and piloting of the curriculum. Other partners include the OASAS, the AIDS Community Research Initiative of America (ACRIA), and the NYC DOHMH. These trainings helped promote vaccination of high-risk adults by preparing providers to offer vaccination services. Table) . Collaborations have extended the reach of the AHVP from STD clinics to a broad array of settings reaching those with various risk factors (Figure 1) 
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Although hepatitis vaccination for adults is now well established in STD clinics statewide, startup was slow and required active involvement of the BSTDC. Collaborating with partner organizations, the AHVP gained access to a broad spectrum of people at high risk. 5 Making hepatitis vaccines available to providers is an important component of a comprehensive adult hepatitis vaccination program. Getting busy providers to administer vaccine or make referrals requires promotion, follow-up, training, and materials, and building a comprehensive program requires a long-term commitment and a continued focus on the needs of individuals at risk. Partnerships can lead to new models of service delivery. For instance, in late 2005, the AIDS Institute arranged a meeting between the OASAS and the AHVP to discuss strategies for vaccination of adults receiving substance abuse treatment services. By early 2006, the AHVP and OASAS were linking substance abuse treatment programs and LHD adult immunization programs. A pilot program in two counties is underway and being evaluated for possible expansion to other counties. Another initiative involving AHVP, BSTDC, the AIDS Institute, the NYS Department of Correctional Service, and the NYS Commission of Correction is expected to improve the transfer of vaccination information when inmates move from jails to prisons, between prisons, and between jails.
Funding for the implementation of Advisory Committee on Immunization Practices recommendations for screening and vaccination of all people at risk for hepatitis A and B is needed to supplement existing local resources and make needed resources available in jurisdictions without existing capacity. It would benefit both insurers and patients if full coverage for hepatitis A and B vaccination were available to adults who indicate that they are at risk, without requiring them to disclose specific risks. Prevention education and interventions are crucial, and educational materials suitable for diverse populations are needed. Existing guidance is available to inform health departments about challenges and strategies to overcome them. 7, 17 "Eliminating Hepatitis: A Call to Action" (April 2006), a plan by the National Viral Hepatitis Roundtable, underscores the urgent need to discover and resolve barriers to vaccination of adults at risk for hepatitis A and B. 18 The experience in NYS demonstrates that hepatitis vaccinations can be provided in a variety of settings where adults at high risk seek services. Indian health centers
